Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant

Human Pathology

Volumn 42, Issue 4, 2011, Pages 500-506

  Smith, Robert Anthony ^a   Salajegheh, Ali ^a   Weinstein, Stephen ^a   Nassiri, Mohammad ^a   Lam, Alfred King Yin ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

BRAF' V600E; Follicular variant; Hashimoto thyroiditis; Lymphocytic thyroiditis; Papillary thyroid carcinoma

Indexed keywords

B RAF KINASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; DNA EXTRACTION; DNA SEQUENCE; EXON; FEMALE; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; POLYMERASE CHAIN REACTION; THYROID CARCINOMA; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; YOUNG ADULT;

EID: 79952985927     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.09.023     Document Type: Article

References (36)

1. Correa P., and Chen V.W. Endocrine gland cancer Cancer 75 1995 338 352
2. Lam A.K.Y., Lo C.Y., and Lam K.S.L. Papillary carcinoma of thyroid: a 30-year clinicopathological review of the histologic variants Endocr Pathol 16 2005 323 330
3. Salajegheh A., Petcu E.B., Smith R.A., and Lam A.K.Y. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists Postgrad Med J 84 2008 78 82 (Pubitemid 351427573)
4. Lang B.H., Lo C.Y., Chan W.F., Lam A.K., and Wan K.Y. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome World J Surg 30 2006 752 758 (Pubitemid 43724102)
5. Lloyd R.V., Erickson L.A., and Casey M.B. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma Am J Surg Pathol 28 2004 1336 1340 (Pubitemid 39336372)
6. Burgess J.R. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997) Thyroid 12 2002 141 149 (Pubitemid 34213998)
7. Lam K.Y., Lo C.Y., and Leung P.S. High prevalence of RET protooncogene activation (RET/PTC) in papillary thyroid carcinomas Eur J Endocrinol 147 2002 741 745 (Pubitemid 36032962)
8. Lam K.Y., Montone K.T., and Nolan K.A. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters Hum Pathol 29 1998 565 568 (Pubitemid 28272709)
9. Lo C.Y., Lam K.Y., Leung P.P., and Luk J.M. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma Eur J Endocrinol 152 2005 545 550 (Pubitemid 40575799)
10. Lam A.K., Lo C.Y., and Leung P. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma Ann Surg Oncol 14 2007 1772 1779 (Pubitemid 46790989)
11. Zhu Z., Gandhi M., and Nikiforova M.N. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations Am J Clin Pathol 120 2003 71 77 (Pubitemid 37046372)
12. Fagin J.A., and Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications Best Pract Res Clin Endocrinol Metab 22 2008 955 969
13. Ciampi R., Knauf J., and Kerler R. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer J Clin Invest 115 2005 94 101 (Pubitemid 40385509)
14. Xing M., Westra W., and Tufano R. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 2005 6373 6379 (Pubitemid 41759286)
15. Ciampi R., and Nikiforov Y.E. Alterations of the BRAF gene in thyroid tumors Endocr Pathol 16 2005 163 172 (Pubitemid 41687187)
16. Pratilas C.A., Taylor B.S., and Ye Q. (V600E) BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway Proc Natl Acad Sci USA 106 2009 4519 4524
17. Vasko V., Hu S., and Wu G. High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes J Clin Endocrinol Metab 90 2005 5265 5269 (Pubitemid 41262284)
18. DeLellis R.A., and Williams E.D. Tumours of the thyroid and parathyroid R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs 2004 IARC Press Lyon 49 56
19. Sobin L.H., and Wittekind C.H. Thyroid gland L.H. Sobin, C.H. Wittekind, 6th ed. International Union against Cancer (UICC) TNM classification of malignant tumours 2002 Wiley-Liss New York 52 56
20. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci Ann Hum Genet 59 1995 97 105
21. Trovisco V., Soares P., and Preto A. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness Virchows Arch 446 2005 589 595 (Pubitemid 40922263)
22. Trovisco V., Vieira de Castro I., and Soares P. BRAF mutations are associated with some histological types of papillary thyroid carcinoma J Pathol 202 2004 247 251 (Pubitemid 38208663)
23. Espadinha C., Santos J.R., Sobrinho L.G., and Bugalho M.J. Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAF V600E mutation dependency Clin Endocrinol (Oxf) 70 2009 629 635
24. Di Cristofaro J., Marcy M., and Vasko V. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant Hum Pathol 37 2006 824 830 (Pubitemid 43902941)
25. Nikiforova M.N., Kimura E.T., and Gandhi M. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 2003 5399 5404 (Pubitemid 37452745)
26. Barnier J.V., Papin C., Eychène A., Lecoq O., and Calothy G. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression J Biol Chem 270 1995 23381 23389
27. Hmitou I., Druillennec S., Valluet A., Peyssonnaux C., and Eychène A. Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms Mol Cell Biol 27 2007 31 43 (Pubitemid 46013230)
28. Baitei E.Y., Zou M., and Al-Mohanna F. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma J Pathol 217 2009 707 715
29. Nucera C., Goldfarb M., Hodin R., and Parangi S. Role of B-Raf (V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E) Biochim Biophys Acta 1795 2009 152 161
30. Namba H., Nakashima M., and Hayashi T. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers J Clin Endocrinol Metab 88 2003 4393 4397 (Pubitemid 37153748)
31. Mesa C. Jr, Mirza M., and Mitsutake N. Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling Cancer Res 66 2006 6521 6529 (Pubitemid 44085606)
32. Li W.Q., Kawakami K., and Ruszkiewicz A. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status Mol Cancer 5 2006 2
33. Edlundh-Rose E., Egyházi S., and Omholt K. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing Melanoma Res 16 2006 471 478 (Pubitemid 44934704)
34. Andersen M.H., Fensterle J., and Ugurel S. Immunogenicity of constitutively active V599EBRaf Cancer Res 64 2004 5456 5460
35. Sumimoto H., Imabayashi F., Iwata T., and Kawakami Y. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells J Exp Med 203 2006 1651 1656 (Pubitemid 44036269)
36. Kim S.K., Song K.H., and Lim S.D. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis Thyroid 19 2009 137 141